Suzhou Zelgen Biopharmaceuticals Co.,ltd

This study tests a new drug called ZG005 combined with standard chemotherapy (gemcitabine and cisplatin) as a first treatment for people with advanced gallbladder cancer. The goal is to see if the combination shrinks tumors better than chemo alone. About 60 adults with confirmed …

This study tests a new drug called ZGGS18 in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see how well the drug is tolerated. About 222 participants will take part in this early-phase trial.

This study tests whether combining two experimental drugs, ZG006 and ZG005, can shrink tumors in people with advanced small cell lung cancer or neuroendocrine carcinoma. About 350 adults aged 18 to 70 will take part. The goal is to see if the combination is safe and works better …

This study tests a new drug called ZG006 in people with small cell lung cancer or neuroendocrine carcinoma who have run out of standard treatments or can't tolerate them. The main goals are to find a safe dose and check for side effects. About 54 adults aged 18 to 75 will take pa…

This study tests a new two-drug combination (ZG005 and gecacitinib) in people with advanced non-small cell lung cancer that has not responded to standard PD-1/L1 therapy. The goal is to see if the combination is safe and can shrink tumors. About 50 adults aged 18 to 75 will take …

This study tests a new drug called ZGGS34 in about 400 people with advanced solid tumors that have not responded to standard treatments. The trial has two parts: first, finding a safe dose, and second, checking if the drug works alone or with chemotherapy. Only people whose tumor…

This study tests a new drug called ZG006 in people with advanced small cell lung cancer or neuroendocrine carcinoma. The first part finds a safe dose, and the second part checks how well that dose shrinks tumors. About 265 adults aged 18-75 with good performance status are being …

This study tests a combination of two experimental drugs, ZGGS18 and ZG005, in people with advanced solid tumors (cervical, liver, neuroendocrine, or lung cancer) who have run out of standard options. The main goals are to find a safe dose and see if the drugs can shrink tumors. …

This study tests whether combining two drugs, ZG005 and gecacitinib (with or without bevacizumab), is safe and can shrink tumors in people with advanced cervical cancer. About 120 women aged 18–75 whose cancer has spread or returned will take part. The goal is to find the best do…

This study tests whether the experimental drug ZG006 can help people with relapsed small cell lung cancer live longer compared to standard chemotherapy. About 420 adults aged 18 to 75 who are in fairly good health will be randomly assigned to receive either ZG006 or a chemotherap…

This study tests a new drug called ZG006 combined with standard immunotherapy (with or without chemotherapy) as a first treatment for people with extensive-stage small cell lung cancer. The goal is to see if the combination is safe and to find the right dose. About 100 adults age…

This study is testing a new two-drug combination (ZG005 and gecacitinib) for people with lymphoma that has returned or hasn't responded to previous treatments. The first part aims to find a safe and effective dose, while the second part will measure how well the combination works…